Drugs + Money
FDA Cracks Down on Marketing of Kratom to People With Opioid Use Disorder
In the past year, a debate has intensified over how kratom—a plant with mild ...
Could Ending Asset Forfeiture Be a First Step Towards Reparations?
Coinciding with Juneteenth, a day honoring the emancipation of enslaved peoples, Congress held the ...
All-Time High European Cocaine Supply Underlines Rationale for Fair Trade
Cocaine, most widely used illicit stimulant in European Union countries, is surging in the ...
How One City Invests Cannabis Tax Dollars Into Black-Owned Businesses
Small cannabis business-owners of color in Portland, Oregon are getting a serious leg-up in ...
Eurasian States Pouring Money Into Incarceration, Not Harm Reduction
Harm reduction funding around the world is stalling. By extension, harm reductionists in Eastern ...
Global Drug Survey: Large Majority of Cocaine Users Would Pay More for Safer, “Fair Trade” Supply
As the international cocaine supply becomes increasingly risky, most people who use the drug ...
Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors?
On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive ...
Maine Hit Hard by Overdose Crisis, Yet Suffers Biggest Federal Funding Shortfall
Funding for harm reduction interventions in Maine received a much-needed boost on February 6. ...
Bernie Sanders Backs #BreakThePatent Fight for Universal PrEP Access
The fight for universal access to PrEP medication for HIV prevention was picked up ...
New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand
It’s been less than two weeks since the US Department of Justice joined a ...
